Hughes Financial Services’s ADMA Biologics ADMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$259 Buy
22
+21
+2,100% +$194 ﹤0.01% 1389
2026
Q2
$8 Hold
1
– – ﹤0.01% 1817
2026
Q1
$9 Sell
1
-11
-92% -$174 ﹤0.01% 1688
2025
Q4
$219 Buy
+12
New +$202 ﹤0.01% 985

Other funds holding ADMA

Hughes Financial Services's ADMA Position: Q3 2026 in Review

Hughes Financial Services increased its ADMA Biologics (ADMA) stake by 2,100% in Q3 2026, buying an estimated $194 and bringing the position to 22 shares worth $259. The position accounts for ﹤0.01% of the portfolio, ranked #1389.

Hughes Financial Services first reported a position in ADMA in Q4 2025 and has held it in 4 quarters since. 330 funds tracked by Wall St. Rank hold ADMA as of Q3 2026.

  • Hughes Financial Services held 22 shares of ADMA Biologics worth $259 as of Q3 2026.
  • Hughes Financial Services bought 21 ADMA Biologics shares in Q3 2026, an estimated $194.
  • ADMA Biologics made up ﹤0.01% of Hughes Financial Services's portfolio in Q3 2026, its #1389 holding.
  • Hughes Financial Services first reported a position in ADMA Biologics in Q4 2025 and has held it in 4 quarters since.
  • 330 funds tracked by Wall St. Rank held ADMA Biologics as of Q3 2026.

Based on Hughes Financial Services's 13F filing for Q3 2026, filed 30 Oct 2026.